Summit Therapeutics Inc. (SMMT.O) 2Q26 Model Update

Research evidence excerpt

Summit Therapeutics Inc. (SMMT.O) 2Q26 Model Update

Summit Therapeutics Inc. (SMMT.O)

24 July 2026 Citi Research

European regulations require a 5 year price history when past performance of a security is referenced. CitiVelocity’s Charting

Tool (https://www.citivelocity.com/cv2/#go/CHARTING_3_Equities) provides the facility to create customisable price charts

including a five year option. This tool can be found in the Data & Analytics section under any of the asset class menus in

CitiVelocity (https://www.citivelocity.com/). For further information contact CitiVelocity support

(https://www.citivelocity.com/cv2/go/CLIENT_SUPPORT). The source for all referenced prices, unless otherwise stated, is

DataCentral, which sources price information from LSEG Data & Analytics. Past performance is not a guarantee or reliable

indicator of future results. Forecasts are not a guarantee or reliable indicator of future performance.

Investors should always consider the investment objectives, risks, and charges and expenses of an ETF carefully before

investing. The applicable prospectus and key investor information document (as applicable) for an ETF should contain this and

other information about such ETF. It is important to read carefully any such prospectus before investing. Clients may obtain

prospectuses and key investor information documents for ETFs from the applicable distributor or authorized participant, the

exchange upon which an ETF is listed and/or from the applicable website of the applicable ETF issuer. The value of the

investments and any accruing income may fall or rise. Any past performance, prediction or forecast is not indicative of future or

likely performance. Any information on ETFs contained herein is provided strictly for illustrative purposes and should not be